78 related articles for article (PubMed ID: 1076757)
1. [Synthetic studies on antiatherogenic agents (II) syntheses of carbamate derivative of phthalazinones (author's transl)].
Ishikawa M; Egughi Y; Sugimoto A
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():145-68. PubMed ID: 1076757
[No Abstract] [Full Text] [Related]
2. [Synthetic studies of antiatherogenic agents. (VI) Syntheses of carbamate derivative of substituted phthalazinones (author's transl)].
Eguchi Y; Ishikawa M
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():49-53. PubMed ID: 284539
[No Abstract] [Full Text] [Related]
3. [Synthetic studies on antiatherogenic agents (III) syntheses of carbamate derivative of quinazolinones (author's transl)].
Ishikawa M; Egughi Y; Kaneshiro S
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():169-81. PubMed ID: 1076758
[No Abstract] [Full Text] [Related]
4. [Synthetic studies on antiatherogenic agents (I). Syntheses of carbamate derivatives of diazines (author's transl)].
Ishikawa M; Eguchi Y
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1974; 8():9-20. PubMed ID: 4534365
[No Abstract] [Full Text] [Related]
5. [Synthetic studies of antiatherogenic agents. (VII) Syntheses of methylcarbamate of substituted quinazolinones (author's transl)].
Eguchi Y; Ishikawa M
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():55-9. PubMed ID: 284540
[No Abstract] [Full Text] [Related]
6. [Pyridinol-carbamate and atherosclerosis. Clinical studies and animal experiments].
de Oliveira JM
Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5303765
[No Abstract] [Full Text] [Related]
7. [Pyridinol carbamate in atherosclerosis].
Sanwald R
Dtsch Med Wochenschr; 1972 Apr; 97(14):583-4. PubMed ID: 5022146
[No Abstract] [Full Text] [Related]
8. [Pyridinol-carbamate and atherosclerosis. Clinical observations and animal experimentation].
de Oliveira JM
Hospital (Rio J); 1968 Sep; 74(3):799-806. PubMed ID: 5310119
[No Abstract] [Full Text] [Related]
9. The effect of pyridinol carbamate treatment on the platelet response to ADP in patients with peripheral atherosclerosis.
Cotton RC; Bloor K; Archibald G
Br J Surg; 1972 Apr; 59(4):313. PubMed ID: 5020777
[No Abstract] [Full Text] [Related]
10. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
Shimamoto T; Numano F; Fujita T; Atsumi T
Rev Atheroscler (Paris); 1967; 9(2):294-306. PubMed ID: 6064255
[No Abstract] [Full Text] [Related]
11. [Evaluation of pyridinol carbamate treatment of coronary atherosclerosis].
Aguirre LV; Eseverri JL; Fajardo D; Ciliberti E; Quijano E; Lucerelli R
Prensa Med Argent; 1970 Jun; 57(16):778-83. PubMed ID: 5457375
[No Abstract] [Full Text] [Related]
12. [Value of pyridinol carbamate in ocular vascular pathology (Angioxine)].
Boudet ; Millet ; Arnaud
Bull Soc Ophtalmol Fr; 1974; 74(9-10):977-80. PubMed ID: 4470033
[No Abstract] [Full Text] [Related]
13. [Contribution of pyridinol-carbamate in ophthalmologic therapeutics].
Pouliquen Y; Guyot-Argenton C
Nouv Presse Med; 1972 Jan; 1(3):199-200. PubMed ID: 5061538
[No Abstract] [Full Text] [Related]
14. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
15. [Effect of pyridinol carbamate on long-term lathyrism and experimental atheroma in the rat. Histological and biochemical study].
Bouissou H; de Graeve J; Julian M; Pieraggi MT; Thiers JC
Paroi Arterielle; 1980; 6(1):3-15. PubMed ID: 7422355
[TBL] [Abstract][Full Text] [Related]
16. [Anginin in the treatment of coronary artery disease].
Markiewicz M; Korolko A; Jaroszyński G
Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
[No Abstract] [Full Text] [Related]
17. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
Bouissou H; Julian M; Pieraggi MT
Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172
[No Abstract] [Full Text] [Related]
18. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
19. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
20. [Modifications of dyslipemia of atherosclerotic origin using pentosan polysulphonic ester].
Kabanchik M; Fernández F; Sermukslis B; Smud R; Palermo G
Prensa Med Argent; 1967 Dec; 54(39):2137-42. PubMed ID: 4901929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
